-
Featured Authors
Archive
- May 2013 (2)
- April 2013 (5)
- March 2013 (2)
- February 2013 (4)
- January 2013 (1)
- December 2012 (2)
- November 2012 (3)
- October 2012 (3)
- September 2012 (3)
- August 2012 (5)
- July 2012 (4)
- June 2012 (7)
- May 2012 (5)
- April 2012 (3)
- March 2012 (4)
- February 2012 (6)
- January 2012 (2)
- December 2011 (2)
- November 2011 (3)
- October 2011 (3)
- September 2011 (5)
- August 2011 (4)
- July 2011 (8)
- June 2011 (16)
- May 2011 (8)
- April 2011 (9)
- March 2011 (14)
- February 2011 (9)
- January 2011 (15)
- December 2010 (7)
- November 2010 (6)
- October 2010 (4)
- June 2010 (1)
- May 2010 (4)
- April 2010 (14)
- March 2010 (4)
- January 2010 (5)
- November 2009 (3)
- October 2009 (1)
- August 2009 (6)
- July 2009 (9)
- June 2009 (9)
- May 2009 (8)
- April 2009 (9)
- March 2009 (9)
- February 2009 (3)
- January 2009 (1)
- November 2008 (1)
Category Archives: Patently BIOtech
BIO Members Receive Patents for Humanity Award
The United States Patent and Trademark Office announced the winners of the Patents for Humanity awards. “The Patents for Humanity is a competition recognizing patent owners and licensees who address global challenges in health and standards of living.” The USPTO website provides this background on the BIO member winners: “Gilead Sciences “Of the 35 million people worldwide suffering from HIV, 95% live in developing countries. Gilead produces antiretroviral therapies for the treatment of HIV. They Read More >
Patent and Tech Transfer Sessions at 2013 BIO International Convention
Patent and Technology Transfer sessions feature prominently at the 2013 BIO International Convention in Chicago from April 22-25, 2013. Topics cover developing patent and tech transfer issues in the U.S. and internationally. Many of the sessions provide Continuing Legal Education (CLE) and Registered Technology Transfer Professional (RTTP) credits. The Biotech Patenting and Technology Transfer Track sessions are below: Behind the Tech Transfer Headlines: What are You Missing? Headline-making news reports of multiyear, multimillion dollar strategic Read More >
Kirtsaeng v. John Wiley & Sons: No Good Deed Goes Unpunished
The Supreme Court handed Kirtsaeng a victory last week finding his importation and resale of copyrighted books exhausted the copyright under the First Sale Doctrine. In a vain attempt at corporate responsibility, the publishers in this case created two versions of textbooks; a no-frills “Asia edition” to sell at affordable prices to students in less affluent places like Thailand, and a higher quality more expensive version to relatively more affluent students in places like the Read More >
BIO IPCC Conference Launches Next Week
BIO’s IPCC Spring Conference is in San Diego next week, March 25-27. Find this year’s line-up below and follow me on twitter at @rzwahlen for live tweeting of the panels. Pre-Conference Workshop: Effecting and Managing Change Sponsored by: Foley & Lardner LLP The panel will discuss lobbying and public messaging about IP. This workshop will provide an overview and illustrative anecdotes on how to lobby Congress and the administration on certain issues. and how to Read More >
Gene Patents: Common Sense from Down Under
Oh, crikey! The U.S. Supreme Court is currently reviewing briefs to consider whether preparations of DNA molecules are patentable. Possibly unnoticed to the Justices is a recent decision from the Federal Court of Australia confirming the patentability of ‘isolated’ DNA. The Supreme Court may not take any notice of this Australian case, but those following so-called gene patents can learn a lot from the no-nonsense approach of Aussie patent law. The Australian case focuses its Read More >
